Published in Cancer Weekly, September 1st, 1997
Biomira launched its Truquant BR RIA blood test kit for the detection of recurrent breast cancer in the U.S. in 1997, after a three-year clinical trial in patients previously treated for Stage II or Stage III breast cancer. The results,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.